Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 40
2016 1
2017 1
2018 7
2019 8
2021 2
2022 14
2023 18
2024 10
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Related Articles by Review for PMID: 38630973

61 results

Results by year

Filters applied: . Clear all
Page 1
Ritlecitinib.
[No authors listed] [No authors listed] 2024 Mar 25. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. 2024 Mar 25. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. PMID: 38630973 Free Books & Documents. Review.
Baricitinib.
[No authors listed] [No authors listed] 2022 Aug 30. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. 2022 Aug 30. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. PMID: 31643344 Free Books & Documents. Review.
Ritlecitinib: First Approval.
Blair HA. Blair HA. Drugs. 2023 Sep;83(14):1315-1321. doi: 10.1007/s40265-023-01928-y. Drugs. 2023. PMID: 37556041 Free PMC article. Review.
Abrocitinib.
[No authors listed] [No authors listed] 2022 Jun 13. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. 2022 Jun 13. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. PMID: 35782024 Free Books & Documents. Review.
Janus kinase inhibitors for alopecia areata: A narrative review.
Haughton RD, Herbert SM, Ji-Xu A, Downing L, Raychaudhuri SP, Maverakis E. Haughton RD, et al. Indian J Dermatol Venereol Leprol. 2023 Nov-Dec;89(6):799-806. doi: 10.25259/IJDVL_1093_2022. Indian J Dermatol Venereol Leprol. 2023. PMID: 37436019 Free article. Review.
Janus kinase inhibitors for alopecia areata.
King BA, Craiglow BG. King BA, et al. J Am Acad Dermatol. 2023 Aug;89(2S):S29-S32. doi: 10.1016/j.jaad.2023.05.049. J Am Acad Dermatol. 2023. PMID: 37591562 Review.
Pirtobrutinib.
[No authors listed] [No authors listed] 2024 Jul 15. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. 2024 Jul 15. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. PMID: 39110822 Free Books & Documents. Review.
61 results